Why INVO Bioscience Shares Are Trading Higher By Over 31%; Here Are 20 Stocks Moving Premarket
Portfolio Pulse from Lisa Levin
INVO Bioscience, Inc. (NASDAQ:INVO) shares increased by over 31% in pre-market trading due to a narrower Q3 loss and a 314% surge in quarterly sales. Other stocks experienced pre-market movements, with notable gainers including TCRT, AIRE, HRYU, THRX, RDHL, ABSI, PXMD, ADN, OMIC, and losers such as SKIN, HROW, AUVI, AKLI, HTCR, PRSO, FSR, TCON, TENX, XAIR.
November 14, 2023 | 12:41 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
INVO Bioscience's stock surged over 31% in pre-market trading due to a significantly narrower Q3 loss and a 314% increase in sales compared to the previous year.
The substantial reduction in quarterly loss and the impressive increase in sales are strong positive financial indicators that are likely to boost investor confidence and drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100